The effect of GLP-1R agonists on the medical triad of obesity, diabetes, and cancer
<p dir="ltr">Glucagon-like peptide-1 receptor (GLP-1R) agonists have garnered significant attention for their therapeutic potential in addressing the interconnected health challenges of diabetes, obesity, and cancer. The role of GLP-1R in type 2 diabetes mellitus (T2DM) is highlighte...
محفوظ في:
| المؤلف الرئيسي: | Shahad Sabaawi Ibrahim (21842273) (author) |
|---|---|
| مؤلفون آخرون: | Raghad Sabaawi Ibrahim (21842276) (author), Batoul Arabi (21842279) (author), Aranka Brockmueller (11064675) (author), Mehdi Shakibaei (325455) (author), Dietrich Büsselberg (11008857) (author) |
| منشور في: |
2024
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
GLP-1 receptor agonists, are we witnessing the emergence of a paradigm shift for neuro-cardio-metabolic disorders?
حسب: Abdelilah Arredouani (10914455)
منشور في: (2025) -
Efficacy of Semaglutide in Pediatric Patients With Bardet-Biedl Syndrome and Alström Syndrome
حسب: Hajar Dauleh (18002500)
منشور في: (2025) -
Genetic polymorphisms associated with obesity in the Arab world: a systematic review
حسب: Salma Younes (6424865)
منشور في: (2021) -
Exploring Glucagon‐Like Peptide‐1 Receptor Agonists Usage Among Non‐Diabetic Healthcare Providers: A Cross‐Sectional Multi‐Country Study
حسب: Abdulqadir J. Nashwan (11659453)
منشور في: (2025) -
The Landscape of Obesity Education Worldwide — Are We Doing Enough? Scoping Review of Content of Obesity Educational Interventions in Medical Schools and Residency Programs
حسب: Wahiba Elhag (5245547)
منشور في: (2025)